International Biotechnology Trust

Summary

In 1994 was created International Biotechnology Trust, which is appeared as Corporate Investor. The fund was located in Europe if to be more exact in United Kingdom. The main department of described Corporate Investor is located in the London.

The higher amount of exits for fund were in 2018. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this International Biotechnology Trust works on 21 percentage points more the average amount of lead investments. The top activity for fund was in 2001.

The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the International Biotechnology Trust, startups are often financed by SV Health Investors, New Hill Management, IP Group Plc. The meaningful sponsors for the fund in investment in the same round are SV Health Investors, Temasek Holdings, Singapore Bio-Innovations. In the next rounds fund is usually obtained by SV Health Investors, Alta Partners, Skyline Ventures.

Among the various public portfolio startups of the fund, we may underline eBioinformatics, Karus Therapeutics, Aderis Pharmaceuticals For fund there is no match between the location of its establishment and the land of its numerous investments - United States. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. The fund has specific favorite in a number of founders of portfolio startups. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology.